This process has involved a lot of work for everyone and delivered very little

December 12, 2024 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

New updates and an interim evaluation of a significant health system reform have highlighted the broader policy focus on disinvestment and minimal return from a multi-year funded reform process. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Australia at a crossroads as the nuclear medicine revolution gathers pace
March 12, 2026 - Latest News
There is an ideology behind our funding systems, and it's the greatest barrier to change
March 11, 2026 - Latest News
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - Latest News
New Zealand confirms earlier access to breakthrough cystic fibrosis medicines
March 12, 2026 - Latest News
Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs
March 10, 2026

This process has involved a lot of work for everyone and delivered very little

This is a preview of subscriber content

Latest Video

Most Read

Australia at a crossroads as the nuclear medicine revolution gathers pace

There is an ideology behind our funding systems, and it's the greatest barrier to change

CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production

New Zealand confirms earlier access to breakthrough cystic fibrosis medicines

Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs

New Stories

Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer

The leadership challenge behind Australia’s medicine access gap

Australia has spent four decades having the wrong conversation about medicines access

‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event

Australia’s top community pharmacists honoured at national awards

A new prostate cancer technology moves closer to global trials after strong early results

Cell therapy company Mesoblast names executive to guide clinical development and medical affairs

Sign In

This process has involved a lot of work for everyone and delivered very little

This is a preview of subscriber content

Latest Video

Most Read

Australia at a crossroads as the nuclear medicine revolution gathers pace

There is an ideology behind our funding systems, and it's the greatest barrier to change

CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production

New Zealand confirms earlier access to breakthrough cystic fibrosis medicines

Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs

Follow Us

New Stories

Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer

The leadership challenge behind Australia’s medicine access gap

Australia has spent four decades having the wrong conversation about medicines access

‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event

Australia’s top community pharmacists honoured at national awards

A new prostate cancer technology moves closer to global trials after strong early results

Cell therapy company Mesoblast names executive to guide clinical development and medical affairs